Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab)
NCT05320159
·
clinicaltrials.gov ↗
COMPLETED
Status
17743
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
Secukinumab
Sponsor
Novartis Pharmaceuticals